Table 12.
Factors associated with MetS according to NCEP-ATP III criteria, results from univariate and multivariate logistic regression, (CMD- set, N = 476)
| Univariate logistic regression Effect, Visit 1 |
Odds Ratio | 95% CI | p-Value |
|---|---|---|---|
| Age | 1.03 | 1.02 to 1.05 | <.0001 |
| Time since first symptoms (years) | 1.02 | 1.00 to 1.04 | 0.0399 |
| Concomitant somatic disease: Y vs. N | 4.83 | 3.09 to 7.53 | <.0001 |
| Non-psychiatric co-medication: Y vs. N | 3.38 | 2.15 to 5.31 | <.0001 |
| Smoking status: Y vs. N | 0.61 | 0.42 to 0.89 | 0.0107 |
| CRP ≥3 mg/L vs. normal value | 1.68 | 1.11 to 2.56 | 0.0151 |
| Prev-Comb vs. Prev-None | 3.56 | 1.89 to 6.70 | <.0001 |
| Prev-Olz vs. Prev-None | 2.91 | 1.40 to 6.05 | 0.0043 |
| Prev-Atyp vs. Prev-None | 3.27 | 1.72 to 6.24 | 0.0003 |
| Prev-Quet vs. Prev-None | 3.74 | 1.73 to 8.09 | 0.0008 |
| Prev-Risp vs. Prev-None | 2.62 | 1.27 to 5.39 | 0.0091 |
| Prev-Typ vs. Prev-None | 3.07 | 1.59 to 5.91 | 0.0008 |
| Effect, Visit 2 | Odds Ratio | 95% CI | p-Value |
| Age | 1.02 | 1.01 to 1.04 | 0.0042 |
| Time since first symptoms (years) | 1.03 | 1.01 to 1.04 | 0.0059 |
| Concomitant somatic disease: Y vs. N No | 3.98 | 2.57 to 6.19 | <.0001 |
| Non-psychiatric co-medication: Y vs. N No | 2.67 | 1.71 to 4.16 | <.0001 |
| CRP ≥3 mg/L vs. normal value | 2.36 | 1.58 to 3.51 | <.0001 |
| Prev-Comb vs. Prev-None | 2.63 | 1.44 to 4.81 | 0.0017 |
| Prev-Olz vs. Prev-None | 2.63 | 1.30 to 5.33 | 0.0071 |
| Prev-Atyp vs. Prev-None | 2.07 | 1.11 to 3.85 | 0.0216 |
| Prev-Quet vs. Prev-None | 2.38 | 1.13 to 5.04 | 0.0232 |
| Prev-Risp vs. Prev-None | 2.16 | 1.08 to 4.33 | 0.0292 |
| Prev-Typ vs. Prev-None | 2.29 | 1.22 to 4.29 | 0.0098 |
|
Multivariate logistic regression Effect, Visit 1 |
Odds Ratio | 95% CI | p-Value |
| Concomitant somatic disease: Y vs. N | 4.09 | 2.37 to 7.06 | <.0001 |
| Smoking status: Y vs. N | 0.53 | 0.32 to 0.86 | 0.0098 |
| Effect, Visit 2 | Odds Ratio | 95% CI | p-Value |
| CRP ≥3 mg/L vs. normal value | 2.00 | 1.22 to 3.30 | 0.0062 |
| Non-psychiatric co-medication: Y vs. N No: | 1.98 | 0.98 to 4.04 | 0.0588 |
| Concomitant somatic disease: Y vs. N No | 1.83 | 0.93 to 3.61 | 0.0796 |
| Sex: female vs. male | 0.56 | 0.34 to 0.91 | 0.0185 |
| Smoking status at visit 2: Y vs. N | 0.60 | 0.37 to 1.00 | 0.0488 |
Abbreviations: CI = confidence interval; CMD = complete metabolic data; CRP = ; C-reactive protein; MetS = metabolic syndrome; N = No; NCEP-ATP III = National Cholesterol Education Program, Adult Treatment Panel 3rd report; New-AP = new antipsychotic treatment cohort; Y = Yes